Evogene - 50 Year Dividend History | EVGN

Historical dividend payout and yield for Evogene (EVGN) since 1971. The current TTM dividend payout for Evogene (EVGN) as of November 26, 2021 is $0.00. The current dividend yield for Evogene as of November 26, 2021 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.052B $0.001B
Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.
Stock Name Country Market Cap PE Ratio